Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Bullboard Posts
Comment by elgin1on Nov 01, 2019 10:03pm
196 Views
Post# 30300224

RE:RE:RE:RE:RE:11 million shares...

RE:RE:RE:RE:RE:11 million shares...
BioTeck wrote: You own 6 million shares of a high risk, severely dilluted penny stock run by a pack of circus clowns? You are not an investor. You my friend, are a moron.


The group in Germany owns more than 15% of the float collectively to what I hear. It’s my own decision, as in investor . Besides since the recent data, it has been significantly derisked and will be further with more data. On top of that , the floor for the buyout is $1 Billion US which well over $5 Canadian at least . And before you start going about Semma having their own cells etc.... they have no device that is proven to work yet in human trials . Viacycte. Is not getting any measurable c peptide , only some in sentinels , not even in implanted in humans yet! The 1 Billion US valuation is justified because Sernova has Hemophilia and Thyroid as other indications besides diabetes.

Anyways Bioteck it won’t be that long before we find out how this investment turns out . One to two years tops . 

GLTA

Bullboard Posts